Rahul Sharma
Latest contributions
TAVI embolisation - Part 1
18 Nov 2025 – From PCR London Valves 2025
This session explores the critical issue of TAVI valve embolisation, presenting real-world cases that emphasize rapid problem-solving and interventional management strategies. Discussions include bailout techniques for embolised valves, managing multiple valve implantations in severe aortic stenosis, and expectations for TAVI in pure aortic regurgitation. The session...
TAVI in challenging anatomies
18 Nov 2025 – From PCR London Valves 2025
This session focuses on the challenges of performing TAVI in complex anatomical settings. It covers issues such as valve compression, hypertrophic cardiomyopathy-related left ventricular responses, alternative management strategies during crises, and handling anatomical complexities like membranous septal aneurysm at the annulus and sinus of Valsalva in...
TAVI-in-TAVI
16 Nov 2025 – From PCR London Valves 2025
This session explores the nuanced field of TAVI-in-TAVI procedures, focusing on valve durability considerations between bovine and porcine valves, strategies for redo TAVI post valve-in-valve, and advanced interventions to secure coronary flow such as inter-valvular stenting. It highlights complex anatomical challenges including aberrant coronary origins and...
Early treatment of severe aortic stenosis: do we need to wait?
20 May 2025 – From EuroPCR 2025
Rahul Sharma and Darren Walters share their perspectives on shifting treatment strategies for aortic stenosis (AS), with a focus on early intervention.
Their conversation draws on the EARLY TAVR trial, which compared transcatheter aortic valve replacement (TAVR) to clinical surveillance in patients with severe, asymptomatic AS at low surgical...
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
TAVI - Procedural complications
20 May 2025 – From EuroPCR 2025
Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
How to best image the atrioventricular valves?
14 May 2024 – From EuroPCR 2024
This session, in collaboration with the PCR Tricuspid Focus Group, aims to provide a comprehensive understanding of how to image the atrioventricular valves (mitral and tricuspid) to assess their anatomy and pathology. It covers the step-by-step evaluation of the mitral and tricuspid valves using transesophageal echocardiography...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
Latest developments in interventional valve therapies
06 Dec 2023 – From GulfPCR-GIM 2023
In this GulfPCR-GIM 2023 session, learn more about RESILIA, the calcium-blocking tissue found in Edwards' newest innovative system: the Sapien 3 Ultra Resilia. Then, move on from TAVI to the first mitral transcatheter edge-to-edge repair (TEER) performed in the Middle East using the PASCAL Precision System.
